Abstract：Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in preterm infants. Despite significant progress in the understanding of its etiology, mechanisms, prevention, and treatment, the prognosis remains poor. BPD not only has a high mortality rate but also causes persistent respiratory, neurological, and cardiovascular impairments in survivors. The author's team has successfully prevented the occurrence of BPD by managing neonatal lung diseases under lung ultrasound monitoring for nearly 7 years, opening up a new approach in BPD prevention. This article provides a brief overview of the approach, aiming to facilitate further research and provide more scientifically sound management strategies to prevent or minimize the occurrence of BPD.
LIU Jing. Management of lung diseases under ultrasound monitoring: potential to make bronchopulmonary dysplasia in preterm infants as an avoidable disease[J]. CJCP, 2024, 26(1): 14-18.
Bancalari E, Jain D. Bronchopulmonary dysplasia: 50 years after the original description[J]. Neonatology, 2019, 115(4): 384-391. PMID: 30974430. DOI: 10.1159/000497422.
Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375: n1974. PMID: 34670756. DOI: 10.1136/bmj.n1974.
Lal CV, Kandasamy J, Dolma K, et al. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia[J]. Am J Physiol Lung Cell Mol Physiol, 2018, 315(5): L810-L815. PMID: 30113227. PMCID: PMC6295508. DOI: 10.1152/ajplung.00085.2018.
Pammi M, Lal CV, Wagner BD, et al. Airway microbiome and development of bronchopulmonary dysplasia in preterm infants: a systematic review[J]. J Pediatr, 2019, 204: 126-133.e2. PMID: 30297287. DOI: 10.1016/j.jpeds.2018.08.042.
Luo X, Zhao M, Chen C, et al. Identification of genetic susceptibility in preterm newborns with bronchopulmonary dysplasia by whole-exome sequencing: BIVM gene may play a role[J]. Eur J Pediatr, 2023, 182(4): 1707-1718. PMID: 36757497. PMCID: PMC10167099. DOI: 10.1007/s00431-022-04779-z.
Doyle LW. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia[J]. Neonatology, 2021, 118(2): 244-251. PMID: 33975319. DOI: 10.1159/000515950.
Ferrante G, Montante C, Notarbartolo V, et al. Antioxidants: role the in prevention and treatment of bronchopulmonary dysplasia[J]. Paediatr Respir Rev, 2022, 42: 53-58. PMID: 35177319. DOI: 10.1016/j.prrv.2022.01.003.
Gentle SJ, Rysavy MA, Li L, et al. Heterogeneity of treatment effects of hydrocortisone by risk of bronchopulmonary dysplasia or death among extremely preterm infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: a secondary analysis of a randomized clinical trial[J]. JAMA Netw Open, 2023, 6(5): e2315315. PMID: 37256621. PMCID: PMC10233424. DOI: 10.1001/jamanetworkopen.2023.15315.
Siffel C, Kistler KD, Lewis JFM, et al. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review[J]. J Matern Fetal Neonatal Med, 2021, 34(11): 1721-1731. PMID: 31397199. DOI: 10.1080/14767058.2019.1646240.
Liu J, Zhang X, Wang Y, et al. The outcome- or cost-effectiveness analysis of LUS-based care or CXR-based care of neonatal lung diseases: the clinical practice evidence from a level Ⅲ NICU in China[J]. Diagnostics (Basel), 2022, 12(11): 2790. PMID: 36428848. PMCID: PMC9689125. DOI: 10.3390/diagnostics12112790.
Katz TA, Vliegenthart RJS, Aarnoudse-Moens CSH, et al. Severity of bronchopulmonary dysplasia and neurodevelopmental outcome at 2 and 5 years corrected age[J]. J Pediatr, 2022, 243: 40-46.e2. PMID: 34929243. DOI: 10.1016/j.jpeds.2021.12.018.
Gao YQ, Qiu RX, Liu J, et al. Lung ultrasound completely replaced chest X-ray for diagnosing neonatal lung diseases: a 3-year clinical practice report from a neonatal intensive care unit in China[J]. J Matern Fetal Neonatal Med, 2022, 35(18): 3565-3572. PMID: 33032479. DOI: 10.1080/14767058.2020.1830369.
Liu J, Xia RM, Ren XL, et al. The new application of point-of-care lung ultrasound in guiding or assisting neonatal severe lung disease treatment based on a case series[J]. J Matern Fetal Neonatal Med, 2020, 33(23): 3907-3915. PMID: 30835592. DOI: 10.1080/14767058.2019.1590332.
28 Qiu RX, Ren XL, Liu J, et al. Bronchoalveolar lavage to treat neonatal meconium aspiration syndrome under monitoring of lung ultrasound based on a prospective case series study[J]. Iran J Pediatr, 2019, 29(4): e90012. DOI: 10.5812/ijp.90012.
Liu J, Zhao HR, Wei HL, et al. Efficacy of bronchoalveolar lavage as adjunct therapy in the treatment of neonatal severe pneumonia: a prospective case-control study[J]. J Trop Pediatr, 2020, 66(5): 528-533. PMID: 32065644. DOI: 10.1093/tropej/fmaa010.
30 Ren XL, Wang M, Liu J, et al. The application of point-of-care lung ultrasound in the precise nursing of neonatal severe pneumonia[J]. Chest, 2019, 155(4): 87A. DOI: 10.1016/j.chest.2019.02.086.
Liu J, Fu W, Qin SJ. Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: a retrospective investigation study[J]. Front Pediatr, 2022, 10: 952315. PMID: 36340730. PMCID: PMC9635001. DOI: 10.3389/fped.2022.952315.
